Startseite

Palmitoyl Hexapeptide-12

Palmitoyl Hexapeptide-12

Spezifikationen

171263-26-6CAS-Nummer
2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-(hexadecanoylamino)-3-methylbutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acidIUPAC-Name
C38H68N6O8Chemische Formel
737 g/molMolekulargewicht
Palmitoyl hexapeptide-12; 171263-26-6; HO4ZT5S86C; Palmitoyl hexapeptide-12 [INCI]; N-Palmitoyl-val-gly-val-ala-pro-gly; Glycine, N-(1-oxohexadecyl)-L-valylglycyl-L-valyl-L-alanyl-L-prolyl-; RefChem:858424; 2-((S)-1-((2S,5S,11S)-5,11-Diisopropyl-2-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctacosan-1-oyl)pyrrolidine-2-carboxamido)acetic acid; 2-[[(2S)-1-[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-(hexadecanoylamino)-3-methylbutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acid; C38H68N6O8; Lipopeptide acetate; N-(1-Oxohexadecyl)-L-valylglycyl-L-valyl-L-alanyl-L-prolylglycine; Lipopeptide; Biopeptide El; MFCD11974932; Palmitoyl hexapeptide 12; Palmitoyl hexapeptide-12?; UNII-HO4ZT5S86C; orb1943199; SCHEMBL23230092; JFSQSDAOQLNSQI-DTBJPNGVSA-N; DTXSID401018159; Palmitoyl Hexapeptide-12 (Powder); Palmitoyl Hexapeptide-12 (Liquid); AKOS027321446; DA-75030; DS-11734; HY-66015; CS-0005655; T81566; F866362; Q27280026; palmitoyl-L-valylglycyl-L-valyl-L-alanyl-L-prolylglycine; N-Hexadecanoyl-L-valylglycyl-L-valyl-L-alanyl-L-prolylglycine; 2-((S)-1-((2S,5S,11S)-5,11-Diisopropyl-2-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctacosan-1-oyl)pyrrolidine-2-carboxamido)aceticacid; 2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-(hexadecanoylamino)-3-methyl-butanoyl]amino]acetyl]amino]-3-methyl-butanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acidSynonyme